Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8(+) Immunity In Vivo

doi:10.1016/j.omtn.2017.10.015

Chia Nan University of Pharmacy & Science Institutional Repository > 智慧生活學院 > 高齡福祉養生管理系 > 期刊論文 > Item 310902800/31729

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31729

標題:	Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8(+) Immunity In Vivo
作者:	Weng, Tzu-Yang Li, Chia-Jung Li, Chung-Yen Hung, Yu-Hsuan Yen, Meng-Chi Chang, Yu-Wei Chen, Yu-Hung Chen, Yi-Ling Hsu, Hui-Ping Chang, Jang-Yang Lai, Ming-Derg
貢獻者:	Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci Kaohsiung Med Univ,Kaohsiung Med Univ Hosp, Dept Emergency Med Natl Cheng Kung Univ, Dept Med Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management Natl Cheng Kung Univ, Coll Med,Natl Cheng Kung Univ Hosp, Dept Surg Natl Hlth Res Inst, Natl Inst Canc Res
關鍵字:	Human Dendritic Cells Cancer-Immunotherapy Lectin Receptors Dna Vaccine T-Cells Indoleamine 2,3-Dioxygenase Inhibitory Motif Dcir Antigen Immunoreceptor
日期:	2017-12-15
上傳時間:	2018-11-30 15:54:30 (UTC+8)
出版者:	Cell Press
摘要:	Clec4a has been reported to be an immune suppressor of dendritic cells (DCs), but its potential role in cancer therapy remains to be elucidated. The present study investigated whether downregulating the expression of Clec4a via skin delivery of small hairpin RNA (shRNA) using a gene gun produced stronger host immunity and inhibited tumor progression in animal models. Administration of Clec4a2 shRNA delayed tumor growth in both mouse bladder and lung tumor-bearing mouse models. The result was further confirmed with a compensation experiment showing that the antitumor effects induced by Clec4a2 shRNA were restored by co-injection of a plasmid expressing exogenous Clec4a2. Increased numbers of infiltrating CD4(+) and CD8(+) T cells at tumor sites were observed in mice treated with Clec4a2 shRNA. Splenocytes from mice with Clec4a2 shRNA administration exhibited stronger cytotoxic activity compared with splenocytes from control mice. CD8-deletion in vivo abrogated the antitumor effects elicited by Clec4a2 shRNA. Additionally, shClec4a enhanced the antitumor effects of the Neu DNA vaccine in the MBT-2 tumor model. In summary, the findings provide evidence that silencing of Clec4a2 expression via skin delivery of shRNA produces an effective antitumor response and that Clec4a2 shRNA may have therapeutic potential as an adjuvant for cancer immunotherapy.
關聯:	Molecular Therapy-Nucleic Acids, v.9, pp.419-427
顯示於類別:	[高齡福祉養生管理系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
10.1016-j.omtn.2017.10.015.pdf		1788Kb	Adobe PDF	1	檢視/開啟
index.html		0Kb	HTML	1358	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....